UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Jul 9, 2026
Sale
Calculated transaction value
$843.27K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Jul 9, 2026
Public filing date
Jul 10, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$552.48
Jul 9, 2026
Close before public filing
$552.48
Jul 9, 2026
Return since public filing
-7.17%
Through Aug 24, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,536 shares @ $549.01
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000095
Filing cohort
Transactions in this filing
Showing 10 of 10
Trades
10
Issuers
1
Estimated value
$6.52M
Buys / sales
0 / 8
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Jul 9, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Jul 9, 2026 | $241.19K |
| United Therapeutics Corp UTHR Current | Sale | Jul 9, 2026 | $843.27K |
| United Therapeutics Corp UTHR | Sale | Jul 9, 2026 | $798.78K |
| United Therapeutics Corp UTHR | Sale | Jul 9, 2026 | $1.58M |
| United Therapeutics Corp UTHR | Sale | Jul 9, 2026 | $910.32K |
| United Therapeutics Corp UTHR | Sale | Jul 9, 2026 | $443.19K |
| United Therapeutics Corp UTHR | Sale | Jul 9, 2026 | $354.7K |
| United Therapeutics Corp UTHR | Sale | Jul 9, 2026 | $66.69K |
| United Therapeutics Corp UTHR | Exercise | Jul 9, 2026 | $0 |